Kyowa Kirin reports new registry data showing overall survival benefit with mogamulizumab in advanced CTCL

Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis

PureTech highlights Phase 2b data supporting deupirfenidone's safety and efficacy in older IPF patients

Trellus Health signs contract with leading global CRO and expands clinical trial offerings

Ipsen to acquire French biotech ImCheck Therapeutics in deal worth up to EUR1billion

GSK reports positive Phase III data for low-carbon version of Ventolin inhaler

Terns Pharmaceuticals reports topline 12-week data from Phase 2 trial of TERN-601 in obesity

Alligator Bioscience granted US patent for ATOR-4066 bispecific antibody

Citius Oncology and McKesson sign US distribution agreement for LYMPHIR

Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio

Genentech's Gazyva (obinutuzumab) receives US FDA approval to treat adults with lupus nephritis

Merck reports long-term survival benefits of Keytruda in non-small cell lung cancer

Transgene and BioInvent report sustained anti-tumour activity from BT-001 in advanced refractory cancers

Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults

Avacta reports promising Phase 1a data for faridoxorubicin at ESMO 2025